Literature DB >> 11432164

[Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].

I Szántó1, A Vörös, G Gonda, P Nagy, A Altorjay, J Banai, E M Gamal, E Cserepes.   

Abstract

Nowadays the terminology used for the definition of adenocarcinomas at the oesophagogastric junction is "cardiac carcinoma", which can be easily misunderstood. This definition of adenocarcinomas of the oesophagogastric junction does not allow correct comparison of diagnosis (endoscopic, radiological and pathologic), epidemiology and surgical therapy in national and international aspects, because different tumours can develope in the same area, and all called cardia tumors. Siewert and Stein recommended a classification to solve this problem. The classification of the tumours is morphological/topographical. Type I is adenocarcinoma of the distal part of the oesophagus. Type II is adenocarcinoma of the real cardia and type III is subcardial gastric adenocarcinoma. At classification, we always consider results of endoscopy (ortograde and retroflexed view of the oesophago-gastric junction), the x-rays of the oesophagus and stomach, findings at the operation and pathohistologic results. Between 1/1/1974 and 31/12/2000, a total number of 50,878 upper panendoscopic examinations were performed at the Endoscopic Laboratory of the Surgical Department. Adenocarcinoma of the cardia was diagnosed in 488 patients. According to the Siewert-Stein classification, type I tumour was found in 123 (25.2%), type II in 240 (49.18%), and type III was present in 125 (25.61%) patients. The importance of this classification is it enables unified pre-operative assessment and it can also help to decide the type of the surgical intervention. In our patients with type I cancer--depending of the size of the tumour--distal 2/3 oesophagectomy with the resection of the proximal lesser curve of the stomach or total gastrectomy were performed. In the first group oesophago-jejuno-gastrostomy, in case of total gastrectomy Roux-en-Y loop anastomosis was created. In patients with types II and III cancers total gastrectomy was performed. In every patient lymphadenectomy was performed. We suggest the use of this new classification in clinical, gastroenterology--with special regard to the endoscopy--and pathology.

Entities:  

Mesh:

Year:  2001        PMID: 11432164

Source DB:  PubMed          Journal:  Magy Seb        ISSN: 0025-0295


  3 in total

Review 1.  Epidemiology of esophageal cancer.

Authors:  Yuwei Zhang
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

2.  Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.

Authors:  Mohan Suntharalingam; Kathryn Winter; David Ilson; Adam P Dicker; Lisa Kachnic; André Konski; A Bapsi Chakravarthy; Christopher J Anker; Harish Thakrar; Naomi Horiba; Ajay Dubey; Joel S Greenberger; Adam Raben; Jeffrey Giguere; Kevin Roof; Gregory Videtic; Jondavid Pollock; Howard Safran; Christopher H Crane
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

3.  Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.

Authors:  Qifan Yin; Wenhao Wang; Huining Liu; Guang Yang; Shaohui Zhou; Lijun Liu
Journal:  J Cardiothorac Surg       Date:  2019-11-27       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.